Local pharmacists say they are ready to answer the call if they are expected to help the rollout of the COVID-19 vaccine.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
Australians at high risk, such as the elderly and healthcare workers, are expected to be among the earliest to get the jab.
When the initial phases are complete and the vaccine is made available to the general population, Griffith pharmacies want to be on the front lines, helping get it out to as many people as possible.
Sean Dodd, a pharmacist at John Dodd Pharmacy, says they "want to be involved".
"We're like everyone else, we want things to get back to normal," he said.
About 16 million doses of the vaccine will be sent out for use on the general public, and Mr Dodd says this means pharmacies will be crucial to taking pressure off doctors.
If we were given the chance to get involved we'd be fine, we'd be ready to go.
- Pharmacist Kym Ramsey
"If they were to rely on just doctors and nurses to do it they'd have to be doing incredible amounts," he said. "They'd need to administer about 100 doses a day just to keep up."
"Pharmacies are very accessible, if we can spread the work across doctors, nurses and pharmacists we'll allow people to access the vaccine no matter what."
Many pharmacies already help deliver flu and whooping cough vaccines to the general public, and Priceline Pharmacy's Kym Ramsey says adding the COVID-19 vaccine to their service wouldn't be a problem.
"If we were given the chance to get involved we'd be fine, we'd be ready to go," Mr Ramsey said.
"We do yearly vaccines for people anyway, and people in the local community have a good relationship with phamacists."
READ MORE
"They're used to coming in regularly, so adding the vaccine to something we can offer is probably a good idea."
This was a sentiment echoed by Leanne Foley, a pharmacist at Amcal+.
"I think we should be involved," she said. "We've definitely got the immunisation skills to do it all."
Ms Foley said it was important for apprehensive members of the public to be educated on the "gold standard" testing the vaccine has undergone.
"The studies look really good," she said. "They've done thousands of tests and hopefully when people notice the elderly and the healthcare workers getting the vaccine and being fine, they will understand it is safe."
The vaccine is expected to be made available to the general public by late August or early July, though this is subject to change.